Prevalence of antibodies to hepatitis C virus in hemodialysis patients in Riyadh.

Prevalence of antibodies to hepatitis C virus (anti-HCV) was determined in 190 adults (mean age 40.4 years; range 15 to 75) with end-stage renal disease (ESRD) who are on regular hemodialysis in the Nephrology Unit, Riyadh Central Hospital. The overall prevalence rate was 53.

Prevalence of antibodies to hepatitis C virus in blood donors in Riyadh.

Prevalence of antibodies to hepatitis C virus (anti-HCV) was determined in 580 voluntary blood donors in Riyadh. Among 403 Saudis screened, the prevalence was 1.24%, while among 177 expatriates screened the prevalence was 4.

Prevalence of antibodies to hepatitis C virus in Saudi patients with chronic liver disease.

The prevalence of antibodies to hepatitis C virus (anti-HCV) has been measured in 113 Saudi patients with chronic liver diseases. Twenty-five percent of 20 patients with hepatocellular carcinoma (HCC) were positive for anti-HCV and 29.7% of 38 patients with cirrhosis and 27.